Harvard Apparatus Regenerative Technology,

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch HRGN and buy or sell other stocks, ETFs, and their options commission-free!

About HRGN

Harvard Apparatus Regenerative Technology, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. 

CEO
Jun Li He
CEOJun Li He
Employees
8
Employees8
Headquarters
Holliston, Massachusetts
HeadquartersHolliston, Massachusetts
Founded
2012
Founded2012
Employees
8
Employees8

HRGN Key Statistics

Market cap
33.66M
Market cap33.66M
Price-Earnings ratio
-4.47
Price-Earnings ratio-4.47
Dividend yield
Dividend yield
Average volume
360.30
Average volume360.30
High today
$1.95
High today$1.95
Low today
$1.91
Low today$1.91
Open price
$1.91
Open price$1.91
Volume
150.00
Volume150.00
52 Week high
$4.40
52 Week high$4.40
52 Week low
$0.9359
52 Week low$0.9359
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.